Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Bixi Sun"'
Publikováno v:
Drug Delivery, Vol 27, Iss 1, Pp 772-781 (2020)
Effective nose-to-brain delivery needs to be developed to treat neurodegenerative diseases. Regulating miR-124 can effectively improve the symptoms of ischemic brain injury and provide a certain protective effect from brain damage after cerebral isch
Externí odkaz:
https://doaj.org/article/c74fce2caec94f9d9589eb973c9adb96
Autor:
Yu Su, Bixi Sun, Xiaoshu Gao, Xinyue Dong, Lanbo Fu, Yingxin Zhang, Zhulin Li, Yue Wang, Hongyu Jiang, Bing Han
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Effective treatments for neurodegenerative diseases need to be developed. MiR132 is abundantly expressed in the brain, and it modulates neuron morphology and plays a key role in maintaining neuron survival. Regulating miR132 can effectively improve t
Externí odkaz:
https://doaj.org/article/0a190e6801e942659164b396dfa65ba6
Publikováno v:
Pharmaceutics, Vol 12, Iss 10, p 907 (2020)
To prepare a binary formulation delivering miRNA-146 and evaluate a nucleic acid nasal delivery system by investigating its pharmacodynamic effects in allergic rhinitis. The gel/NPs/miR-146a thermosensitive in situ chitosan hydrogel carrying a nuclei
Externí odkaz:
https://doaj.org/article/7dd2931d111c4f45a5893f3f528013d3
Publikováno v:
Pharmaceutics, Vol 12, Iss 6, p 575 (2020)
Studies have shown that microRNA-133 (miR-133) plays a positive role in the growth of cardiac myocytes, the maintenance of cardiac homeostasis, and the recovery of cardiac function, which is of great significance for the recovery of acute myocardial
Externí odkaz:
https://doaj.org/article/fa8601e66e3846418d3a75202f734f47
Versatile modification of the CRISPR/Cas9 ribonucleoprotein system to facilitate in vivo application
Publikováno v:
Journal of Controlled Release. 337:698-717
The development of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems has created a tremendous wave that is sweeping the world of genome editing. The ribonucleoprotein (RNP) method has evolved to be the
Publikováno v:
Drug Delivery
Drug Delivery, Vol 27, Iss 1, Pp 772-781 (2020)
Drug Delivery, Vol 27, Iss 1, Pp 772-781 (2020)
Effective nose-to-brain delivery needs to be developed to treat neurodegenerative diseases. Regulating miR-124 can effectively improve the symptoms of ischemic brain injury and provide a certain protective effect from brain damage after cerebral isch
Publikováno v:
International journal of biological macromolecules. 181
With the development of modern biomedicine, research on the molecular mechanism of tumors has developed gradually. The CD147 gene has been applied to tumor molecular targeted therapy, and significant differences were found in the expression of the CD
Publikováno v:
Pharmaceutics, Vol 12, Iss 907, p 907 (2020)
Pharmaceutics
Volume 12
Issue 10
Pharmaceutics
Volume 12
Issue 10
To prepare a binary formulation delivering miRNA-146 and evaluate a nucleic acid nasal delivery system by investigating its pharmacodynamic effects in allergic rhinitis. The gel/NPs/miR-146a thermosensitive in situ chitosan hydrogel carrying a nuclei
Autor:
Xiaoshu Gao, Lanbo Fu, Bing Han, Yingxin Zhang, Xinyue Dong, Yue Wang, Yu Su, Bixi Sun, Zhulin Li, Hong-yu Jiang
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology
Frontiers in Pharmacology
Effective treatments for neurodegenerative diseases need to be developed. MiR132 is abundantly expressed in the brain, and it modulates neuron morphology and plays a key role in maintaining neuron survival. Regulating miR132 can effectively improve t
Autor:
Bing Han, Siqi Pan, Bixi Sun, Xiaoshu Gao, Ahmed Mohammed Ismail, Shuwen Liu, Yu Su, Xinyue Dong, Rubin Hao
Publikováno v:
Neurochemical research. 45(10)
Mitochondrial abnormalities accelerate the progression of ischemic brain damage. Sirtuin 3 (SIRT3) is mainly found in mitochondria and affects almost all major aspects of mitochondrial function. Luteolin, a flavonoid with diverse biological propertie